Golub Leads $300 Million Loan for Pest Control Company Greenix

Golub Capital led a private credit loan of approximately $300 million to support private equity firm Gridiron Capital's acquisition of pest control company Greenix. This significant transaction, which also involved participation from Churchill Asset Management, Morgan Stanley's private credit arm, and Apogem Capital, highlights the continued robust activity and capital deployment within the private credit market to facilitate middle-market M&A.

Analysis

Golub Capital has led a syndicated private credit loan of approximately $300 million to finance Gridiron Capital's acquisition of Greenix, a pest control company. The participation of other significant lenders, including Churchill Asset Management, Morgan Stanley’s private credit arm, and Apogem Capital, underscores the institutional appetite for well-structured, sponsor-backed deals in the middle market. This transaction highlights the continued robust activity and capital deployment within the private credit space, which serves as a critical funding source for private equity M&A. The choice of a target in the defensive and non-cyclical pest control industry is indicative of lenders' preference for assets with stable, recurring cash flows, a particularly attractive quality in the current macroeconomic environment. For Golub (GBDC) and Morgan Stanley (MS), this deal represents successful capital deployment in their direct lending strategies, reinforcing their market position and origination capabilities.

Key Decisions for Investors

• Investors in Golub Capital (GBDC) should view its leadership role in this $300 million deal as a positive reinforcement of its strong origination platform and ability to secure transactions in defensive sectors.
• The transaction serves as a strong indicator of health and liquidity in the private credit market for funding middle-market M&A, suggesting a favorable environment for BDCs and direct lending funds with established sponsor relationships.
• For investors monitoring Morgan Stanley (MS), this participation highlights the continued growth and execution of its private credit arm, contributing to diversified, fee-based revenues that are less correlated with public market volatility.